We employed five breast cancer cell lines in this study: two HER2-negative (MDA-MB-231 and TM91) and three HER2-positive (SKBR3, HCC1954, and JIMT-1) (Supplementary Fig. S5d). The gene discussed is ERBB2; the disease is breast carcinoma.